Harvard Bioscience Net Profit Margin 2010-2023 | HBIO

Harvard Bioscience net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
Harvard Bioscience Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-12-31 $0.11B $-0.00B -2.68%
2023-09-30 $0.11B $-0.00B -2.68%
2023-06-30 $0.11B $-0.01B -4.39%
2023-03-31 $0.11B $-0.00B -1.75%
2022-12-31 $0.11B $-0.01B -8.85%
2022-09-30 $0.12B $-0.01B -5.93%
2022-06-30 $0.12B $-0.00B -3.31%
2022-03-31 $0.12B $-0.01B -4.96%
2021-12-31 $0.12B 0 0.00%
2021-09-30 $0.12B $-0.00B -1.71%
2021-06-30 $0.11B $-0.00B -2.70%
2021-03-31 $0.11B $-0.01B -4.76%
2020-12-31 $0.10B $-0.01B -8.82%
2020-09-30 $0.10B $-0.01B -6.86%
2020-06-30 $0.11B $-0.01B -8.57%
2020-03-31 $0.11B $-0.01B -6.25%
2019-12-31 $0.12B $-0.00B -3.45%
2019-09-30 $0.12B $-0.00B -1.68%
2019-06-30 $0.12B $0.00B 0.83%
2019-03-31 $0.12B 0 0.00%
2018-12-31 $0.12B $-0.00B -1.64%
2018-09-30 $0.11B $-0.00B -3.64%
2018-06-30 $0.10B $-0.00B -4.00%
2018-03-31 $0.09B $-0.00B -3.45%
2017-12-31 $0.08B 0 0.00%
2017-09-30 $0.08B $-0.00B -2.44%
2017-06-30 $0.09B $-0.00B -4.55%
2017-03-31 $0.10B $-0.01B -5.26%
2016-12-31 $0.10B $-0.01B -4.81%
2016-09-30 $0.11B $-0.02B -19.81%
2016-06-30 $0.11B $-0.02B -18.69%
2016-03-31 $0.11B $-0.02B -17.27%
2015-12-31 $0.11B $-0.02B -17.43%
2015-09-30 $0.11B $-0.00B -1.80%
2015-06-30 $0.11B 0 0.00%
2015-03-31 $0.11B $0.00B 0.93%
2014-12-31 $0.11B $0.00B 2.78%
2014-09-30 $0.11B $0.00B 1.89%
2014-06-30 $0.11B 0 0.00%
2014-03-31 $0.11B $-0.00B -0.95%
2013-12-31 $0.11B $-0.00B -1.90%
2013-09-30 $0.11B 0 0.00%
2013-06-30 $0.11B $0.00B 0.94%
2013-03-31 $0.11B $0.00B 1.85%
2012-12-31 $0.11B $0.00B 2.73%
2012-09-30 $0.11B $0.00B 2.70%
2012-06-30 $0.11B $0.00B 2.70%
2012-03-31 $0.11B $0.00B 2.73%
2011-12-31 $0.11B $0.00B 3.70%
2011-09-30 $0.11B $0.01B 4.59%
2011-06-30 $0.11B $0.02B 16.51%
2011-03-31 $0.11B $0.02B 17.59%
2010-12-31 $0.11B $0.02B 17.59%
2010-09-30 $0.11B $0.02B 19.81%
2010-06-30 $0.10B $0.01B 8.91%
2010-03-31 $0.09B $0.01B 7.53%
2009-12-31 $0.09B $0.01B 8.14%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.166B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.730B 32.82
Bruker (BRKR) United States $11.486B 30.63
Kewaunee Scientific (KEQU) United States $0.103B 12.11